Asensus Surgical, Inc.
ASXCAMEXHealthcare
$0.35
+$0.00(+0.64%)
Market Cap$94922082
P/E Ratio—
52W High$0.3993
52W Low$0.169
Asensus Surgical, Inc. (ASXC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ASXC · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $8.58M | $7.09M | $8.23M | $3.17M | $8.53M |
| Cost of Revenue | $13.15M | $10.87M | $11.10M | $5.17M | $20.73M |
| Gross Profit | ($4.58M) | ($3.79M) | ($2.86M) | ($1.99M) | ($12.20M) |
| Gross Margin %(computed) | -53.38% | -53.41% | -34.79% | -62.71% | -143.01% |
| Operating Expenses | |||||
| R&D Expenses | $37.02M | $28.94M | $19.35M | $16.62M | $22.47M |
| G&A Expenses | $19.16M | $20.17M | $19.32M | $14.14M | $18.76M |
| Total Operating Expenses | $73.10M | $71.58M | $63.32M | $54.62M | $79.54M |
| Operating Income | ($79.47M) | ($75.68M) | ($64.62M) | ($60.39M) | ($154.57M) |
| Operating Margin %(computed) | -926.52% | — | -784.97% | — | — |
| Interest Income | $1.55M | $1.14M | $0.59M | $0.04M | $0.58M |
| Interest Expense | $0.00M | $0.41M | $0.37M | $0.02M | $3.61M |
| Income Before Tax | ($78.12M) | ($75.24M) | ($62.24M) | ($60.83M) | ($157.32M) |
| Income Tax Expense | $0.31M | $0.32M | $0.23M | ($1.52M) | ($3.12M) |
| Net Income | ($78.43M) | ($75.56M) | ($62.46M) | ($59.31M) | ($154.20M) |
| Net Margin %(computed) | -914.46% | — | -758.77% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.31 | $-0.32 | $-0.28 | $-0.85 | $-8.69 |
| Wtd Avg Shares | 249.69M | 236.49M | 226.96M | 70.81M | 17.74M |
| EBITDA | ($74.40M) | ($64.29M) | ($47.76M) | ($47.11M) | ($141.25M) |
| EBITDA Margin %(computed) | -867.45% | -907.11% | -580.13% | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Asensus Surgical, Inc. data
About Asensus Surgical, Inc. (ASXC) Income Statement
Asensus Surgical, Inc. (ASXC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, ASXC reported revenue of $0.01B, gross profit of ($0.00B) (gross margin -53.38%), and net income of ($0.08B) — a net profit margin of -914.46%.
Frequently asked questions
ASXC · 4 questionsAsensus Surgical, Inc. (ASXC) reported revenue of $0.01B for 2023, up 21.0% year-over-year.
ASXC revenueASXC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09